Sudarshan Pharma Industries Ltd - Prospectus Synopsis

Sudarshan Pharma Industries Ltd RHP

Registered Office : 301 3rd Floor Aura Biplex , SV Road Borivali(West) , Mumbai - 400092 , Maharashtra , India.

Phone : 91-22-42221111 Fax :

Email :compliance.spil@gmail.com Website : www.sudarshanpharma.com

Public issue of 68,62,400 equity shares of face value of Rs. 10.00 each (Equity Shares) of Sudarshan Pharma Industries Limited (the Company or the Issuer) for cash at a price of Rs. 73.00 per equity share including a share premium of Rs. 63.00 per equity share (the Issue Price) aggregating to Rs. 50.10 crores (The Issue) of which 3,44,000 equity shares aggregating to Rs. 2.51 crores will be reserved for subscription by market maker to the issue (the Market Maker Reservation Portion). The issue less the market maker reservation portion i.e. net issue of 65,18,400 equity shares aggregating to Rs. 47.59 crores (the Net Issue). The issue and the net issue will constitute 28.52% and 27.09% respectively of the post issue paid-up equity share capital of the company. Issue Price : Rs. 73 per equity share of face value of Rs. 10 each. Anchor Investor Issue Price : Rs. 73 per equity shares The issue price is 7.3 times of the face value. Bids can be made for a minimum of 1600 equity shares and in multiples of 1600 equity shares thereafter.

Issue		Money Payable On
Opens On	Closes On	Application	Allotment
3/9/2023 12:00:00 AM	3/14/2023 12:00:00 AM	Rs 73 - 0	Rs 0 - 0
Minimum Application for shares in Nos : 1600 Further Multiples of : 1600

	Rs Cr	Lead Managers to the Issue
Project Cost	42.2	First Overseas Capital Ltd
Project Financed through Current Offer	50.1
Post Issue Equity Share Capital	42.2
Issue Price	Rs. 73

Projects
To set up a dedicated manufacturing facility for pharmaceutical Business

Promoted By

Listing At

Registrar to the Issue

Hemal V Mehta

Hemal Vasantrai Mehta

Sachin V Mehta

Sachin Vasantrai Mehta

KFin Techologies Ltd

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

Sudarshan Pharma Industries Ltd - Prospectus Synopsis

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.